Generics of the top lung cancer treatment will appear, decreasing the overall drug price down by 38% for the disease
As the patent of the most selling lung cancer treatment ‘Alimta(Lilly Korea)’ will expire on the 10th next month, generic products with the same substance are about make sales.
It seems that generics, having 38% cheaper drug price against original product, will help reduce both cost of the Natio...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
